TGM2 and cancer: Furthermore, a recent study showed that PDAC excludes T cells and resists inhibitors of PD-1 checkpoints when cancer cells are coated with covalent heterodimers of CXCL12 and keratin 19 (KRT19) formed by transglutaminase-2 (TGM2).